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General Considerations.  
 All experiments were conducted using standard Schlenk techniques or in a nitrogen 
atmosphere glovebox. All solvents were dried by passage through solvent purification columns, 
further degassed with argon, and stored over activated 3Å molecular sieves. Deuterated solvents 
were purchased from Cambridge Isotope Laboratory and were degassed and dried prior to use. 
Ethyl vinyl ether was degassed and stored over 3Å molecular sieves. 
(H2IMes)(py)2(Cl)2Ru=CHPh,1 (H2IPr)(py)2(Cl)2Ru=CHPh,2 carbodicarbene 1,3 
endo,exo-norbornenyl diethyl diester,4 and 2-isopropoxy-β-methylstyrene5 were prepared 
according to literature procedures. 
Standard NMR spectroscopic experiments were performed using a Varian Inova 400 
MHz spectrometer, and kinetics experiments were conducted on a Varian 600 MHz spectrometer 
with an AutoX probe. 1H were calibrated internally to the residual proteo solvent relative to 
tetramethylsilane. Spectra were analyzed using MestReNova Ver. 10.0 software.  
SEC data were collected using two Agilent PLgel MIXED-B 300 × 7.5 mm columns with 
10 µm beads, connected to an Agilent 1260 Series pump, a Wyatt 18- angle DAWN HELEOS 
light scattering detector, and Optilab rEX differential refractive index detector. The SEC mobile 
phase was THF. Online determination of dn/dc assumed 100% mass elution under the peak of 
interest.  
High-resolution mass spectrometry (HRMS) data was obtained using an Autoflex 
MALDI-TOF instrument for solvent free samples with a benzylidene malononitrile matrix 
(complexes 2 and 3) or on a JEOL MSRoute mass spectrometer using FAB+ ionization 
(complexes 4 and 5).  
The purity of complexes 2 and 3 was established by NMR spectroscopy.  
 
Synthesis of (H2IMes)(CDC)(Cl)2Ru=CHPh (2).  
 
 In a glovebox, a 20 mL scintillation vial was charged with (H2IMes)(py)2(Cl)2Ru=CHPh 
(68.2 mg, 0.094 mmol), carbodicarbene 1 (31.4 mg, 0.103 mmol) and benzene (8 mL). Over 5 
minutes, the solution changed in color from green to orange. After stirring at 25 °C for 3 hours, 
the solution was concentrated in vacuo to afford an orange solid and was triturated twice with 
pentane (5 mL). The orange powder was dissolved in 2 mL of THF, filtered through Celite, 
layered with diethyl ether (8 mL), and stored at –30 °C to afford orange crystals of 
(H2IMes)(CDC)(Cl)2Ru=CHPh (2, 76.1 mg, 93% yield). 1H NMR (400 MHz, C6D6) δ 19.62 (s, 
1H, Ru=CHPh), 9.17 (br s, 1H, o-Ph), 6.91 (overlapping m, 4H, CDC and m-Mes), 6.81 (s, 1H, 
m-Mes), 6.65 (overlapping m, 4H, CDC and Ph), 6.43 (overlapping m, 4H, CDC and Ph), 6.18 
(br s, 2H, CDC), 5.84 (s, 1H, m-Mes), 3.36 (m, 4H, H2IMes NCH2CH2N), 3.25 (br, 12H, CDC), 
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3.10 (s, 3H, Mes), 2.86 (s, 3H, Mes), 2.71 (s, 3H, Mes), 2.23 (s, 3H, Mes), 2.05 (s, 3H, Mes), 
1.89 (s, 3H, Mes); 13C{1H} NMR (101 MHz, C6D6) δ 291.80 (Ru=CHPh), 224.58 (H2IMes 
NCN), 163.40 (CDC NCN), 151.62 (Ph), 148.05 (Ph), 139.75 (Mes), 139.37 (Mes), 138.96 
(Mes), 138.92 (Mes), 138.26 (Mes), 138.06 (Mes), 137.66 (Mes), 137.15 (Mes), 131.14 (Ph), 
130.65 (m-Mes), 130.30 (m-Mes), 129.61 (m-Mes), 129.08 (m-Mes), 122.38 (Ph), 119.37 (CDC), 
109.61 (CDC), 104.05 (CDC), 73.01 (CDC central carbon), 51.74 (H2IMes NCH2CH2N), 51.46 
(H2IMes NCH2CH2N), 31.23 (CDC N-CH3), 21.16 (Mes), 21.05 (Mes), 20.43 (Mes), 20.13 
(Mes), 19.32 (Mes), 18.74 (Mes). HRMS (MALDI-TOF) m/z Calculated for C47H52N6RuCl [M–
HCl]: 837.299; Found: 837.299. 
 
Synthesis of (H2IPr)(CDC)(Cl)2Ru=CHPh (3). 
 
 In a glovebox, a 20 mL scintillation vial was charged with (H2IPr)(py)2(Cl)2Ru=CHPh 
(58.6 mg, 0.0722 mmol), carbodicarbene 1 (25.2 mg, 0.0828 mmol) and benzene (8 mL). Over 5 
minutes, the solution changed in color from green to orange. After stirring at 25 °C for 2 hours, 
the solution was concentrated in vacuo and triturated twice with pentane (5 mL). The orange 
powder was dissolved in benzene (4 mL) and additional carbodicarbene 1 (10.2 mg, 0.0316 
mmol) was added. After 30 minutes, volatile components were removed in vacuo. The solid was 
dissolved in a mixture of diethyl ether (10 mL) and THF (3 mL), filtered through Celite, and 
stored at –30 °C to afford orange crystals of (H2IPr)(CDC)(Cl)2Ru=CHPh (3, 52.2 mg, 75% 
yield). 1H NMR (400 MHz, C6D6) δ 19.67 (s, 1H, Ru=CHPh), 7.39 (s, 4H, Ph and DIPP), 7.22 
(br d, 1H, DIPP), 6.97 (t, J = 8Hz, 1H, Ph), 6.87 (m, 2H, CDC), 6.64 (m, 3H, CDC and Ph), 6.53 
(br d, 1H, DIPP), 6.46 (t, J = 8Hz, 2H, DIPP), 6.38 (br m, 2H, CDC), 6.17 (m, 2H, CDC), 4.77 
(br s, 1H, CH(CH3)2), 4.39 (br s, 1H, CH(CH3)2), 3.97 (s, 2H, H2IPr NCH2CH2N), 3.85 (m, 2H, 
CH(CH3)2), 3.76 (m, 1H, H2IPr NCH2CH2N), 3.52 (m, 1H, H2IPr NCH2CH2N), 3.28 (m, 1H, 
CH(CH3)2), 3.17 (s, 6H, CDC N–CH3), 2.75 (br s, 6H, CDC N–CH3), 2.01 (s, 3H, CH(CH3)2), 
1.71 (br s, 6H, CH(CH3)2), 1.36 (m, 3H, CH(CH3)2), 1.28 (m, 3H, CH(CH3)2), 1.19 (m, 3H, 
CH(CH3)2), 1.05 (m, 3H, CH(CH3)2), 0.98 (m, 3H, CH(CH3)2); 13C{1H} NMR (101 MHz, C6D6) 
δ 294.30 (Ru=CHPh), 227.09 (H2IPr NCN), 162.36 (CDC NCN), 150.85 (Ph), 149.74 (DIPP), 
147.54 (Ph), 139.89 (DIPP), 139.29 (DIPP), 136.43 (DIPP), 130.97 (CDC), 129.27 (Ph), 125.62 
(DIPP), 124.87 (Ph), 124.22 (DIPP), 123.91 (DIPP), 121.89 (CDC), 119.34 (CDC), 108.90 
(CDC), 104.23 (CDC), 73.37 (CDC central C), 54.70 (H2IMes NCH2CH2N), 54.21 (H2IMes 
NCH2CH2N), 30.65 (CDC N–CH3), 30.24 (CDC N–CH3), 28.64 (CH(CH3)2), 28.24 (CH(CH3)2), 
27.61 (CH(CH3)2), 26.91 (CH(CH3)2), 26.58 (CH(CH3)2), 26.56 (CH(CH3)2), 26.40 (CH(CH3)2), 
26.32 (CH(CH3)2), 26.08 (CH(CH3)2), 24.59 (CH(CH3)2), 24.10 (CH(CH3)2), 22.97 (CH(CH3)2). 
HRMS (MALDI-TOF) m/z Calculated for C53H64N6RuCl [M–HCl]: 921.392; Found: 921.394. 
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Attempted Syntheses and Observation of CDC–H+ Formation. 
 
Representative procedure: A solution of (PCy3)2(Cl)2Ru=CHPh (6.6 mg, 0.0080 mmol) and CDC 
1 (2.5 mg, 0.0080 mmol) was prepared in benzene-d6 (0.8 mL). After 24 hours, CDC–H+ had 
precipitated as a pale yellow powder, and was washed with Et2O (5 mL) and dried in vacuo. 1H 
NMR (400 MHz, CD2Cl2) δ 7.38 (m, 8H), 5.23 (s, 1H), 3.64 (s, 12H); 13C{1H} NMR (101 MHz, 
CD2Cl2) δ 153.89, 133.58, 124.53, 110.43, 51.47, 33.06. HRMS (FAB+) : m/z Calculated for 
C19H21N4 [M+]: 305.1766; Found: 305.1762. 
 
Ring-Closing Metathesis of Diethyl Diallylmalonate.  
 
 In a glovebox, a solution of catalyst 2 or 3 (0.00080 mmol) in 0.80 mL of benzene-d6 was 
prepared in a J. Young NMR tube and frozen using a glovebox cold well. An internal standard, 
1,3,5-tris(trifluoromethyl)benzene (1 µL) and diethyl diallylmalonate (19.3 µL, 0.0800 mmol) 
were added, and the NMR tube was stored at 0 °C before use. The tube was placed in an NMR 
spectrometer with the temperature pre-equilibrated to 40 °C. Disappearance of diethyl 
diallylmalonate and appearance of 4,4-dicarbethoxy-1-cyclopentene were monitored by 
comparing the ratio of integrals for the methylene protons of these compounds (δ = 2.86 (dt) and 
3.16 (s), respectively). 
 
 
Figure S1. Log plots for the ring-closing metathesis of diethyl diallylmalonate with catalysts 2 
and 3. 
 
Ru
Cl
Cl
PCy3
O
N
N N
NC
[Ru] +
C6D6
N
N N
NC
H
+ unidentified decomposition 
products
[Ru] =
Ru
N
Cl
Cl
PCy3
Ph
N
Ru
PCy3
Cl
Cl
PCy3
Ph
EtO2C CO2Et 1 mol% 2 or 3
C6D6 (0.1 M), 40 °C
EtO2C CO2Et
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
0 500 1000 1500 2000 2500 
ln
[M
0/M
t] 
time (s) 
2 
3 
S5 
Ring-Opening Metathesis Polymerization of endo,exo-Norbornenyl Diethyl Diester (DEE) 
 
 A solution of DEE (23.8 mg, 0.100 mmol) in dichloromethane (1.75 mL) was prepared in 
a glovebox. While stirring, a solution of catalyst 2 or 3 (0.00080 mmol) in dichloromethane (0.25 
mL) was added. Aliquots (~50 µL) were taken at different time points throughout the reaction 
and immediately quenched in separate vials containing ethyl vinyl ether (0.1 mL) in THF (0.9 
mL). The quenched aliquots were analyzed by SEC and 1H NMR spectroscopy. 
 
 
Figure S2. Size exclusion chromatograms for ROMP of DEE by catalyst 2. 
 
 
Figure S3. Size exclusion chromatograms for ROMP of DEE by catalyst 3. 
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Reaction of 2 with 2-Isopropoxy-β-methylstyrene. 
 
 In a glovebox, a solution of complex 2 (2.6 mg, 0.0030 mmol), 2-isopropoxy-β-
methylstyrene (1.6 µL, 0.0090 mmol), and 1,3,5-tris(trifluoromethyl)benzene (1 µL) as an 
internal standard was prepared in 0.60 mL of benzene-d6 and transferred to a J. Young NMR 
tube. The NMR tube was heated to 40 °C in a temperature-controlled oil bath. After 7 hours, 
complete conversion of 2 to 4 was observed by 1H NMR spectroscopy.6 The identity of 4 was 
verified by HRMS (FAB+): m/z Calculated for C31H38ON2RuCl2 [M+H]–H2: 626.1405; Found: 
626.1397. 
 
Reaction of 3 with 2-Isopropoxy-β-methylstyrene. 
 
 In a glovebox, a solution of complex 3 (2.9 mg, 0.0030 mmol), 2-isopropoxy-β-
methylstyrene (1.6 µL, 0.0090 mmol), and 1,3,5-tris(trifluoromethyl)benzene (1 µL) as an 
internal standard was prepared in 0.60 mL of benzene-d6 and transferred to a J. Young NMR 
tube. The NMR tube was heated to 40 °C in a temperature-controlled oil bath. After 7 hours, 
complete conversion of 3 to 5 was observed by 1H NMR spectroscopy.7 The identity of 5 was 
verified by HRMS (FAB+): m/z Calculated for C37H50ON2RuCl2 [M+H]–H2: 710.2344; Found: 
710.2362. 
 
Reaction of 2 and 3 with Excess Tricyclohexylphosphine. 
 
Complex 2 or 3 (0.0013 mmol) and tricyclohexylphosphine (0.0065 mmol) were 
dissolved in benzene-d6 in a J. Young tube. Exchange of CDC 1 for PCy3 was monitored by 1H 
and 31P NMR spectroscopy at 25 oC.8 After 12 hours, 50% conversion of 2 or 3 was observed, 
along with concomitant formation of the analogous (NHC)(PCy3)(Cl)2Ru=CHPh complex and 
free CDC 1. 
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NMR Kinetics of Initiation Rates. 
 
Complex 2 or 3 (0.0020 mmol) and 0.5 µL of 1,3,5-tris(trifluoromethyl)benzene as an 
internal standard were dissolved in benzene-d6 (0.60 mL) in a screw-capped NMR tube. The 
temperature of the NMR tube was allowed to equilibrate in the NMR probe at 40 oC. Ethyl vinyl 
ether (26 µL, 0.27 mmol) was injected into the NMR tube, and disappearance of the 1H NMR 
signal for the ruthenium benzylidene was monitored as a function of time for three half lives. 
Reactions performed in triplicate provided rate constants (kobs = k1) of (4.04 ± 0.04) × 10–4 s–1 for 
complex 2 and  (9.48 ± 0.07) × 10–3 s–1 for 3. 
 
Table S1. Temperature dependence of kobs for the reaction of 2 (0.0020 mmol) with ethyl vinyl 
ether (0.27 mmol) in benzene-d6 (0.60 mL). 
 
Temp. (oC) 1/T (K–1) kobs (s–1) ln(k/T) 
40 0.00319 4.04 × 10–4  -13.56 
50 0.00309 1.73 × 10–3 -12.14 
58 0.00302 5.48 × 10–3 -11.01 
64 0.00297 1.59 × 10–2 -9.96 
70 0.00291 2.54 × 10–2 -9.51 
 
The plot of ln(k/T) as a function of T–1 (Figure S3) was linearly fit to the expression 
 ln 𝑘T =  −∆H!R ∙ 1T+ ln 𝑘!h +  ΔS!R  
 
The enthalpy and entropy of activation were extracted from the slope and intercept, respectively. 
Standard deviations for ∆H‡ and ∆S‡ were evaluated using the LINEST routine in Excel. 
 
 
Figure S4. Eyring plot for the reaction of 2 with ethyl vinyl ether. 
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Table S2. Temperature dependence of kobs for the reaction of 3 (0.0020 mmol) with ethyl vinyl 
ether (0.27 mmol) in benzene-d6 (0.60 mL). 
 
Temp. (oC) 1/T (K–1) kobs (s–1) ln(k/T) 
25 0.00335 1.05 × 10–3 -12.56 
35 0.00325 5.17 × 10–3 -11.00 
40 0.00319 9.48 × 10–3 -10.41 
55 0.00305 5.42 × 10–2 -8.71 
48 0.00311 2.89 × 10–2 -9.32 
 
 
Figure S5. Eyring plot for the reaction of 3 with ethyl vinyl ether. 
 
 
CDC Dependence Experiments to Determine k–1/k2. 
 
Complex 2 or 3 (0.0020 mmol), CDC (1, 0.0040 to 0.011 mmol), and 1 µL of 1,3,5-
tris(trifluoromethyl)benzene as an internal standard were dissolved in benzene-d6 (0.60 mL) in a 
screw-capped NMR tube. Each sample was thermally equilibrated in the NMR probe, and olefin 
(ethyl vinyl ether, 0.021 to 0.26 mmol) was injected into the NMR tube. Disappearance of the 1H 
NMR signal for the ruthenium benzylidene was monitored as a function of time for three half 
lives. 
 
Table S3. [CDC]/[olefin] experiments for 2 at 60 oC. 
 
[CDC] 
(mmol) 
[olefin] 
(mmol) 
[CDC]/[olefin] kobs 
(s–1) 
1/kobs 
(s) 
0.011 0.22 0.050 7.86 × 10–3 127 
0.011 0.094 0.12 7.37 × 10–3 136 
0.011 0.057 0.19 6.65 × 10–3 150 
0.011 0.031 0.35 5.91 × 10–3 169 
0.011 0.021 0.53 5.39 × 10–3 186 
y = -12664x + 30.012 
R² = 0.99504 
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Figure S6. 1/kobs versus [CDC]/[olefin] for complex 2. 
 
Table S4. [CDC]/[olefin] experiments for 3 at 40 oC. 
 
[CDC] 
(mmol) 
[olefin] 
(mmol) 
[CDC]/[olefin] kobs  
(s–1) 
1/kobs 
(s) 
0.0040 0.26 0.015 9.49 × 10–3 105 
0.011 0.09 0.12 6.58 × 10–3 152 
0.011 0.031 0.35 3.77 × 10–3 265 
0.015 0.035 0.43 3.02 × 10–3 331 
0.011 0.021 0.52 2.79 × 10–3 358 
 
 
Figure S7. 1/kobs versus [CDC]/[olefin] for complex 3. 
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X-Ray Structure Determination. 
 
Complex 2. Low-temperature diffraction data (φ-and ω-scans) were collected on a Bruker 
AXS D8 VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with 
Mo Kα radiation (λ = 0.71073 Å) from an IµS micro-source for the structure of compound 2. The 
structure was solved by direct methods using SHELXS9 and refined against F2 on all data by 
full-matrix least squares with SHELXL-201610 using established refinement techniques.11 All 
non-hydrogen atoms were refined anisotropically. All hydrogen atoms were included into the 
model at geometrically calculated positions and refined using a riding model. The isotropic 
displacement parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms 
they are linked to (1.5 times for methyl groups).  
Complex 2 crystallizes in the monoclinic space group P21/n with one molecule in the 
asymmetric unit.  
 
Complex 3. Low-temperature diffraction data (φ-and ω-scans) were collected on a Bruker 
AXS D8 VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with 
Cu Kα radiation (λ = 1.54178 Å) from an IµS micro-source for the structure of compound 3. The 
structure was solved by direct methods using SHELXS9 and refined against F2 on all data by 
full-matrix least squares with SHELXL-201610 using established refinement techniques.11 All 
non-hydrogen atoms were refined anisotropically. All hydrogen atoms were included into the 
model at geometrically calculated positions and refined using a riding model. The isotropic 
displacement parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms 
they are linked to (1.5 times for methyl groups). All disordered atoms were refined with the help 
of similarity restraints on the 1,2- and 1,3-distances and displacement parameters as well as 
enhanced rigid bond restraints for anisotropic displacement parameters.  
Complex 3 crystallizes in the monoclinic space group P21/c with one molecule in the 
asymmetric unit along with 2.588 molecules of diethyl ether. The crystal was pseudo-
merohedrally twinned. The structure was refined using the twin matrix [-1 0 0 0 -1 0 0 0 1] and 
the twin ratio converged at a value of 0.400(2). 
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Table S5.  Crystal data and structure refinement for complex 2. 
Empirical formula  C47 H52 Cl2 N6 Ru 
Formula weight  872.91 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 14.1398(7) Å α= 90°. 
 b = 23.1163(12) Å β= 115.3760(19)°. 
 c = 14.2265(8) Å γ = 90°. 
Volume 4201.4(4) Å3 
Z 4 
Density (calculated) 1.380 Mg/m3 
Absorption coefficient 0.541 mm-1 
F(000) 1816 
Crystal size 0.300 x 0.150 x 0.050 mm3 
Theta range for data collection 2.370 to 33.142°. 
Index ranges -21<=h<=21, -35<=k<=35, -21<=l<=21 
Reflections collected 74416 
Independent reflections 16014 [R(int) = 0.1090] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7471 and 0.6445 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 16014 / 0 / 515 
Goodness-of-fit on F2 1.009 
Final R indices [I>2sigma(I)] R1 = 0.0534, wR2 = 0.0858 
R indices (all data) R1 = 0.1149, wR2 = 0.0979 
Largest diff. peak and hole 1.264 and -0.774 e.Å-3 
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Figure S8. X-ray crystal structure of complex 2. Displacement ellipsoids are drawn at 50% 
probability, and hydrogen atoms have been omitted for clarity.  
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Table S6.  Crystal data and structure refinement for complex 3. 
Empirical formula  C63.35 H89.88 Cl2 N6 O2.59 Ru 
Formula weight  1148.85 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 12.7525(4) Å α= 90°. 
 b = 32.6167(12) Å β= 90.0724(18)°. 
 c = 14.4122(5) Å γ = 90°. 
Volume 5994.7(4) Å3 
Z 4 
Density (calculated) 1.273 Mg/m3 
Absorption coefficient 3.307 mm-1 
F(000) 2443 
Crystal size 0.300 x 0.100 x 0.050 mm3 
Theta range for data collection 2.709 to 74.488°. 
Index ranges -15<=h<=15, -40<=k<=40, -18<=l<=17 
Reflections collected 86257 
Independent reflections 12234 [R(int) = 0.0709] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.3827 and 0.2333 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12234 / 675 / 753 
Goodness-of-fit on F2 1.294 
Final R indices [I>2sigma(I)] R1 = 0.0826, wR2 = 0.1954 
R indices (all data) R1 = 0.0865, wR2 = 0.1974 
Largest diff. peak and hole 0.774 and -1.539 e.Å-3 
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Figure S9. X-ray crystal structure of complex 3. Displacement ellipsoids are drawn at 50% 
probability, and hydrogen atoms and diethyl ether molecules have been omitted for clarity.  
 
 
 
 
 
 
 
 
S15 
Figure S10. 1H NMR spectrum of 2 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S16 
Figure S11. 13C{1H} NMR spectrum of 2 (in C6D6). Signals for trace diethyl ether are observed 
at 15.63 and 65.94 ppm. 
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Figure S12. COSY NMR spectrum of 2 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S18 
Figure S13. NOESY NMR spectrum of 2 (in C6D6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S19 
Figure S14. 1H-13C HSQC NMR spectrum of 2 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S20 
Figure S15. 1H-13C HMBC NMR spectrum of 2 (in C6D6). 
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Figure S16. 1H NMR spectrum of 3 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S22 
Figure S17. 13C{1H} NMR spectrum of 3 (in C6D6). Signals for trace tetrahydrofuran are 
observed at 25.45 and 67.45 ppm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S23 
Figure S18. COSY NMR spectrum of 3 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S24 
Figure S19. NOESY NMR spectrum of 3 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S25 
Figure S20. 1H-13C HSQC NMR spectrum of 3 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S26 
Figure S21. 1H-13C HMBC NMR spectrum of 3 (in C6D6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S27 
Figure S22. 1H NMR spectrum of CDC–H+ (in CD2Cl2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S28 
Figure S23. 13C{1H} NMR spectrum of CDC–H+ (in CD2Cl2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S29 
References 
 
1. Love, J. A.; Morgan, J. P.; Trnka, T. M.; Grubbs, R. H. Angew. Chem., Int. Ed. 2002, 41, 
4035−4037. 
2. Leitao, E. M.; Piers, W. E.; Parvez, M. Can. J. Chem. 2013, 91, 935–942. 
3. Dyker, C. A.; Lavallo, V.; Donnadieu, B.; Bertrand, G. Angew. Chem. Int. Ed. 2008, 47, 
3206–3209. 
4. Windmon, N.; Dragojlovic, V. Green Chem. Lett. Rev. 2008, 1, 155−163. 
5. Pederson, R. L.; Woertink, J. K.; Haar, C. M.; Gildelberger, D. E.; Schrodi, Y. U. S. Patent 
6,620,955 B1, September 16, 2003. 
6. Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 
8168–8179. 
7. Blum, A. P.; Ritter, T.; Grubbs, R. H. Organometallics, 2007, 26, 2122–2124. 
8. Sauvage, X.; Demonceau, A.; Delaude, L. Adv. Synth. Catal. 2009, 351, 2031–2038. 
9. Sheldrick, G. M. Acta Cryst. 1990, A46, 467-473. 
10. Sheldrick, G. M. Acta Cryst. 2015, C71, 3-8. 
11. Müller, P. Crystallography Reviews 2009, 15, 57-83. 
